Nectar Lifesciences Ltd.
ShareNECLIFE Competitor Analysis
| NECLIFE | SUNPHARMA  | DIVISLAB | TORNTPHARM | CIPLA | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 28 Jan, 2026, 03:56 PM | 13.87 0% | 1,610.60 0% | 6,188.00 0% | 3,958.70 0% | 1,328.40 0% |
| Market cap (₹ Cr) | 311 | 3,86,437 | 1,64,272 | 1,33,980 | 1,07,302 |
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -4.99% | -0.42% | -0.76% | -0.24% | -1.15% |
| 1W | -6.16% | -4.05% | -5.41% | -1.79% | -8.33% |
| 1M | -27.23% | -5.09% | -6.47% | 3.03% | -12.68% |
| 3M | -2.6% | -3.27% | -6.63% | 9.95% | -16.14% |
| 6M | -11.77% | -4.13% | -8.7% | 8.54% | -16.35% |
| 1Y | -57.94% | -4.32% | 11.11% | 18.63% | -7.43% |
| 5Y | -30.38% | 189.16% | 75.28% | 195.23% | 56.19% |
Income StatementAnnual data as on 04 Feb 2026. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 1,670 -0.83% | 52,578 8.41% | 9,360 19.31% | 11,516 7.35% | 27,548 6.88% |
| OPM (%) | -1.76 -119.73% | 28 7.2% | 30.56 13.44% | 32.25 3.3% | 25.09 5.78% |
| PBT | -161.53 -984.13% | 13,752 24.03% | 2,916 34.81% | 2,673 13.65% | 6,821 19.62% |
PAT | -113.68 -2373.6% | 10,980 13.81% | 2,191 36.94% | 1,911 15.4% | 5,291 27.34% |
| Net Profit Margin | -6.81 -2370% | 20.85 5.2% | 23.41 14.75% | 16.6 7.51% | 19.13 18.67% |
| EPS | -5.07 -2404.55% | 45.55 14.13% | 82.53 36.93% | 56.47 15.39% | 65.28 27.87% |
Balance Sheet & Cash FlowAnnual data as on 04 Feb 2026. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 956.11 -10.56% | 72,218 13.43% | 14,969 10.3% | 7,591 10.72% | 31,193 16.8% |
| Total Assets | 2,047 -6.57% | 92,101 7.77% | 16,932 9.45% | 14,990 -0.47% | 37,387 14.27% |
| Total Outside Liabilities | 1,091 -2.76% | 19,883 -8.78% | 1,963 3.37% | 7,399 -9.81% | 6,194 3.04% |
| Cash from Operating Activity | 169.44 -24.59% | 14,072 15.96% | 1,653 31.09% | 2,585 -20.85% | 5,005 21.07% |
| Cash from Investment Activity | -41.93 -146.21% | -5,306 -668.76% | -804 -198.88% | -540.05 -221.65% | -3,691 -23.53% |
| Cash from Financing Activity | -128.09 37.65% | -7,906 -17.82% | -799 0% | -2,298 17.34% | -1,293 -7.75% |
| Net Cash Flow | -0.58 -126.01% | 983.12 -78.91% | 50 -74.09% | -261.66 -180.11% | 30.31 161.87% |
RatiosAnnual data as on 04 Feb 2026. | |||||
| PB | 0.54 | 5.77 | 10.22 | 14.42 | 3.73 |
| PE | N.A. | 35.36 | 74.98 | 70.10 | 20.35 |
| ROE (%) | -11.23 | 16.16 | 15.35 | 26.46 | 18.28 |
| Dividend Yield (%) | 0 | 0.99 | 0.48 | 0.81 | 1.20 |
| ROCE (%) | -5.36 | 20.86 | 20.45 | 27.55 | 23.64 |
